DOCUSATE SODIUM is a brand name for Docusate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: a) To prevent and treat chronic constipation b) As an adjunct in abdominal radiological procedures
Verbatim from this product's MHRA label. Tap a section to expand.
5mg (5ml) to 25mg (10ml) three times daily. Dilute the medicine in a glass of flavoured drink eg fruit juice or milk. Drink the diluted medicine within 30 minutes of preparation. 5mg (5ml) three times daily. Dilute the medicine in a glass of flavoured drink eg fruit juice or milk.
Drink the diluted medicine within 30 minutes of preparation. Adults: not appropriate for adults or elderly. For administration to adults use Docusate Sodium 50mg/5ml or 100mg/5ml oral solution. For barium meals: 75mg (30ml) to be taken with meal.
Frequencies are defined as follows:
Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000), not known (cannot be estimated from the available data).
Gastrointestinal disorders:
Rare: diarrhoea, nausea, abdominal cramps Skin and subcutaneous tissue disorders: Not known: skin rash and pruritus. There have been spontaneous reports of burning sensation in mouth and throat following the use of Docusate sodium. Patients are advised to drink plenty of water or flavoured drink after taking the solution.
Reporting of suspected adverse reactions Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Docusate sodium oral solution should not be given to infants under six months. Prolonged use can precipitate the onset of an atonic nonfunctioning colon and hypokalaemia. Docusate sodium oral solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.
May cause allergic reactions (possibly delayed). 0mg sorbitol in each 5ml dose. The additive effect of concomitantly administered products containing sorbitol (or fructose) and dietary intake of sorbitol (or fructose) should be taken into account.
The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly. Patients with hereditary fructose intolerance (HFI) should not be given this medicinal product.
5% of the WHO recommended maximum daily intake of 2 g sodium for an adult. Docusate sodium oral solution contains propylene glycol. 7 mg propylene glycol in each 5ml dose. If your baby is less than 4 weeks old, talk to your doctor or pharmacist before giving them this medicine, in particular if the baby is given other medicines that contain propylene glycol or alcohol.
1. • in the presence of abdominal pain, intestinal obstruction, nausea or if vomiting occurs.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Docusate in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.